nivolumab
bms
['nivo']
it + iv nivo was safe and well-tolerated in mm pts with lmd, with no unexpected toxicities of the 50 mg mtd of it n. os rates at 6 and 12 mths are encouraging and support further evaluation of it immunotherapy for lmd, including in other tumor types. #asco23 #asco2023 #news 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News